IARC revised "Monographs on Identification of Carcinogenic Hazards to Humans" website (Volumes 1-137)

17 Feb 2025

The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization, revised its website "IARC Monographs on the Identification of Carcinogenic Hazards to Humans" on 14 February 2025.

This revision is to notify the publication of the full paper (online version) of "IARC Monographs Volume 135: Perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS)".

The tentative version of Volume 135 was published earlier on 1 December 2023. There are no modifications on the contents including the carcinogenic hazard classifications of these agents.

The full paper of the IARC Monographs Vol. 135 is available from:
<https://www.iarc.who.int/news-events/iarc-monographs-volume-135-perfluorooctanoic-acid-pfoa-and-perfluorooctanesulfonic-acid-pfos/>

The latest volume of the IARC Monographs is still " Volume 137: hydrochlorothiazide, voriconazole, and tacrolimus".

Related information:
IARC revised "Monographs on Identification of Carcinogenic Hazards to Humans" website (Volumes 1-135)
(posted on 4 Dec 2023)
https://www.jeic-emf.jp/english/academic/info/18232.html

IARC revised "Monographs on Identification of Carcinogenic Hazards to Humans" website (Volumes 1-137)
(posted on 5 Dec 2024)
https://www.jeic-emf.jp/english/academic/info/20241205.html

* Note from JEIC:
There is no change in the carcinogenic hazard categories for EMFs.